Global Enteral Feeding Devices Market is valued at approximately USD 4.5 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2024-2032. Enteral feeding devices are essential medical instruments used to deliver nutrition directly into the gastrointestinal tract, particularly for individuals who cannot ingest food orally due to various health conditions such as neurological disorders, cancers, or severe burns. These devices ensure that patients receive necessary nutrients to maintain their health and recover from illnesses, playing a critical role in healthcare settings.
The market growth is driven by the increasing prevalence of chronic diseases, the rising geriatric population, and a surge in preterm births. Chronic conditions such as diabetes, cancer, neurological disorders, and gastrointestinal diseases are on the rise globally, necessitating the use of enteral feeding devices to ensure patients receive adequate nutrition. Additionally, the growing awareness of the importance of nutrition in patient care is driving the demand for these devices. Technological advancements in enteral feeding devices, coupled with supportive healthcare infrastructure, are further propelling the market. However, stringent regulatory requirements and the need for meticulous management and maintenance of these devices could restrain market growth.
The key regions considered for the global market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the global enteral feeding devices market in 2023, owing to the high prevalence of chronic diseases, advanced healthcare infrastructure, and the presence of key market players. The region's strong focus on improving patient outcomes through innovative medical solutions has led to the widespread adoption of enteral feeding devices in both clinical and home care settings. Meanwhile, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period, driven by a surge in the geriatric population, increasing chronic disease cases, and a rise in preterm births.
Major market players included in this report are:
Cardinal Health Inc.
Fresenius SE & Co. KGaA
Amsino International, Inc.
Nestle S.A.
Becton, Dickinson, and Company
B. Braun SE
Moog Inc.
Avanos Medical, Inc.
Boston Scientific Corporation
Cook Group
Danone
Applied Medical Technology, Inc.
Abbott Laboratories
Medtronic PLC
Vygon SA
The detailed segments and sub-segment of the market are explained below:
By Application
Gastrointestinal Diseases
Cancer
Malnutrition
Neurological Disorders
Other Applications
By End User
Hospitals
Ambulatory Surgical Centers (ASCs)
Home Care
By Product
Enteral Feeding Pumps
Enteral Feeding Tubes
Enteral Syringes
Giving Sets
Others
By Age Group
Adults
Pediatrics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
